Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver.
MacKinnon AC, Humphries DC, Herman K, Roper JA, Holyer I, Mabbitt J, Mills R, Nilsson UJ, Leffler H, Pedersen A, Schambye H, Zetterberg F, Slack RJ.
MacKinnon AC, et al. Among authors: slack rj.
Eur J Pharmacol. 2024 Nov 9:177077. doi: 10.1016/j.ejphar.2024.177077. Online ahead of print.
Eur J Pharmacol. 2024.
PMID: 39528104